FDA seeks further action on manufacturing problems at Genzyme plant

03/24/2010 | Boston Herald · MarketWatch

The FDA intends to "take enforcement action" that might involve hiring a third-party inspection team to investigate manufacturing processes at Genzyme's plant in Allston, Mass., in light of recurring problems. Genzyme Chairman Henri Termeer said the biotech firm is "truly advancing in the recovery of the Allston plant."

View Full Article in:

Boston Herald · MarketWatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN